2-3 toe syndactyly
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
9q22.3 Microdeletion
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
Wilms' tumor in patients with 9q22.3 microdeletion syndrome suggests a role for PTCH1 in nephroblastomas.
|
23169491 |
2013 |
Abnormal Descemet membrane morphology
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Abnormal retinal morphology
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Abnormal uvea morphology
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Abnormality of dental eruption
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Abnormality of skin adnexa morphology
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Abnormality of the face
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Abnormality of the optic nerve
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
|
|
|
Abnormality of the ribs
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the sense of smell
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the skeletal system
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We describe the case of a family in which father and son fulfilled clear cut diagnostic criteria for Gorlin syndrome including multiple basal cell carcinomas, keratocystic odontogenic tumors, atypical skeletal anomalies and a novel PTCH1 germline mutation (c.1041delAA).
|
24941978 |
2014 |
Abnormality of the skeletal system
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
This new Ptch1 allele broadens the mouse genetic reagents available to study the Hedgehog pathway and provides a valuable means to study the underlying skeletal abnormalities in BCNS.
|
23897749 |
2013 |
Abnormality of the sternum
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent nasal septal cartilage
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acanthoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We identified FGFR3 and PTCH1 germline polymorphisms whose influence in the development of reticulated acanthomas is unknown.
|
28627087 |
2017 |
Accessory rib
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acquired Kyphoscoliosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adenocarcinoma
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Shh was expressed in cytoplasm of dysplastic epithelial cells, while expression of Ptch1, Hip and Gli1 were mainly detected in the malignant crypts of adenocarcinomas.
|
17461467 |
2007 |
Adenocarcinoma
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Expression of SHH, PTCH, and GLI1 mRNA was higher in PJPs than in normal tissue (P < .05) and gradually increased along the PJP-adenoma-adenocarcinoma sequence (P < .05).
|
26997450 |
2016 |
Adenocarcinoma
|
0.030 |
GeneticVariation
|
group |
BEFREE |
Here, we have analyzed the mutation status of PTCH1 in a series of 33 colorectal serrated adenocarcinomas by sequencing all 23 coding exons.
|
21234763 |
2011 |
Adenocarcinoma of pancreas
|
0.010 |
Biomarker
|
disease |
BEFREE |
One patient had direct cytological diagnosis of PTC also did not undergo surgical resection/diagnosis due to the advanced primary pancreatic adenocarcinoma.
|
28261999 |
2017 |
Adenocarcinoma, Oxyphilic
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Forty-seven percent (16 of 34) of papillary carcinomas and one oncocytic carcinoma expressed high RET/PTC1 mRNA levels.
|
16595592 |
2006 |
Adenocarcinoma, Oxyphilic
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
CCI = Charlson Comorbidity Index; CCR = California Cancer Registry; CI = confidence interval; DTC = differentiated thyroid cancer; FTC = follicular thyroid carcinoma; HCC = Hürthle cell carcinoma; IQR = interquartile range; mPTC = papillary thyroid micro-carcinoma; OR = odds ratio; OSPHD = Office of Statewide Health Planning and Development; PTC = papillary thyroid carcinoma.
|
28816539 |
2017 |
Adenocarcinoma, Oxyphilic
|
0.030 |
Biomarker
|
disease |
BEFREE |
RNA was isolated from multinodular goiter (MNG; n=6), papillary carcinoma (PTC, n=14), follicular carcinoma (FC; n=5), and Hürthle cell carcinoma (HCC; n=7).
|
24559275 |
2014 |